ftInvstr
VIMTALABS · Healthcare ₹504.9 -0.37% Mkt Cap ₹2257 Cr

VIMTALABS

Healthcare Diagnostics & Research
₹504.9
-0.37% today · 30d -6.85%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for VIMTALABS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2024-12-31
REVENUE
₹90 Cr
+10.09% YoY
NET PROFIT
₹21 Cr
+112.16% YoY
OPM
37.64%
+10.11pp YoY
EPS
₹7.86
PE 28.55
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-2.1%, h2=-1.4%, h3=+0.9% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
VIMTALABS28.55—
SAILIFE103.8124.25
LALPATHLAB57.3731.74
SYNGENE94.416.59
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
62
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation REASONABLE 60
Growth STRONG 80
Profitability HIGH 90
Technicals WEAK 40
Risk LOW 80
Key Stats
TTM PE
28.55
P/B
4.62
52W HIGH
₹735.0
OFF HIGH
-31.31%
DIV YIELD
0.4%
MKT CAP
₹2257 Cr
◉ Active Signals
MACDNeutral4.6728
RSI(14)Neutral43.53
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VIMTALABS and at what entry.

Sign up freeSign in